Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

The Finviz API: Higher Limits, Clearer Data, and More Ways to Connect

Get Started Now

NuCana plc

Contributing Author

Recent Articles by NuCana plc

Sep-30	NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in Europe NCNA +11.57% GlobeNewswire
Aug-13	NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update NCNA NCNA +7.43% GlobeNewswire
Jun-01	NuCana Appoints Ian Webster as Chief Financial Officer NCNA -6.87% GlobeNewswire
May-14	NuCana Reports First Quarter 2026 Financial Results and Provides Business Update NCNA +5.88% NCNA +10.10% GlobeNewswire
Mar-19	NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update NCNA GlobeNewswire
Jan-06	NuCana Appoints Theresa Bruce as Chief Operating Officer NCNA GlobeNewswire
Dec-10	NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma NCNA GlobeNewswire
Nov-13	NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update NCNA -7.92% GlobeNewswire
Nov-05	NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China NCNA GlobeNewswire
Oct-18	NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 NCNA GlobeNewswire
Oct-14	NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy NCNA GlobeNewswire
Sep-05	NuCana Compliant with All Nasdaq Continued Listing Criteria NCNA GlobeNewswire
Sep-03	NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025 NCNA GlobeNewswire
Aug-20	NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update NCNA -12.64% NCNA +6.43% GlobeNewswire
Aug-01	NuCana Announces ADS Ratio Change NCNA -8.86% NCNA +16.88% GlobeNewswire
Jul-21	NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution NCNA +6.92% GlobeNewswire
Jul-11	NuCana Announces Plan to Implement ADS Ratio Change NCNA -15.91% GlobeNewswire
Jun-02	NuCana Reports First Quarter 2025 Financial Results and Provides Business Update NCNA +7.65% NCNA +57.37% GlobeNewswire
May-06	NuCana Prices $7 Million Registered Direct Offering NCNA -63.27% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)